SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001564590-21-026969
Filing Date
2021-05-12
Accepted
2021-05-12 16:00:40
Documents
64
Period of Report
2021-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q scph-10q_20210331.htm 10-Q 1303226
2 EX-31.1 scph-ex311_6.htm EX-31.1 10682
3 EX-32.1 scph-ex321_7.htm EX-32.1 8142
  Complete submission text file 0001564590-21-026969.txt   5816533

Data Files

Seq Description Document Type Size
4 XBRL INSTANCE DOCUMENT scph-20210331.xml EX-101.INS 1342688
5 XBRL TAXONOMY EXTENSION SCHEMA scph-20210331.xsd EX-101.SCH 45696
6 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE scph-20210331_cal.xml EX-101.CAL 49585
7 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE scph-20210331_def.xml EX-101.DEF 132471
8 XBRL TAXONOMY EXTENSION LABEL LINKBASE scph-20210331_lab.xml EX-101.LAB 372577
9 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE scph-20210331_pre.xml EX-101.PRE 285932
Mailing Address 2400 DISTRICT AVENUE SUITE 310 BURLINGTON MA 01803
Business Address 2400 DISTRICT AVENUE SUITE 310 BURLINGTON MA 01803 617-517-0730
scPharmaceuticals Inc. (Filer) CIK: 0001604950 (see all company filings)

IRS No.: 465184075 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-38293 | Film No.: 21914973
SIC: 2834 Pharmaceutical Preparations